Novo Nordisk teams with trending weight loss app Noom to help obesity patients
Novo Nordisk is hooking up with new-wave weight loss program Noom to support people with obesity.
The beyond-the-pill partnership will offer solutions for long-term behavior change and education for people with obesity in the U.S. As part of the deal, patients taking Novo's Saxenda who are enrolled in the SaxendaCare support program can get free access to Noom for 12 months.
Novo Nordisk struck the deal after an eight-month pilot that found patients in SaxendaCare who also used Noom gained “significant value from the combined offering,” Camilla Sylvest, Novo executive vice president in commercial strategy and corporate affairs, said via email.
“Obesity being a chronic disease requires a full spectrum of ongoing weight management strategies: lifestyle change, increased physical activity and diet, as well as pharmacotherapy or other medical interventions. Noom’s digital weight management offering combines the power of artificial intelligence, mobile technology and psychology with the empathy of human coaches,” she said.
Written by: Beth Snyder Bulik
Published on: Oct 11, 2019 11:58am